These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10937709)

  • 21. Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists.
    Hamaguchi N; True TA; Saussy DL; Jeffs PW
    Biochemistry; 1996 Nov; 35(45):14312-7. PubMed ID: 8916917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
    Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
    J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a potent and selective alpha 1A antagonist. Utilization of a rapid screening method to obtain pharmacokinetic parameters.
    Adkison KK; Halm KA; Shaffer JE; Drewry D; Sinhababu AK; Berman J
    Pharm Biotechnol; 1998; 11():423-43. PubMed ID: 9760690
    [No Abstract]   [Full Text] [Related]  

  • 24. Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
    Minarini A; Budriesi R; Chiarini A; Leonardi A; Melchiorre C
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1353-8. PubMed ID: 9871765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (+/-)-Domesticine, a novel and selective alpha1D-adrenoceptor antagonist in animal tissues and human alpha 1-adrenoceptors.
    Indra B; Matsunaga K; Hoshino O; Suzuki M; Ogasawara H; Muramatsu I; Taniguchi T; Ohizumi Y
    Eur J Pharmacol; 2002 Jun; 445(1-2):21-9. PubMed ID: 12065190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative structure-activity relationship study of new potent and selective antagonists at the 5-HT(1A) and adrenergic alpha(1d) receptors: Derivatives of spiroethyl phenyl(substituted)piperazine.
    Sharma BK; Singh P; Sharma S
    J Enzyme Inhib Med Chem; 2006 Oct; 21(5):601-7. PubMed ID: 17194034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.
    Khatuya H; Hutchings RH; Kuo GH; Pulito VL; Jolliffe LK; Li X; Murray WV
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2443-6. PubMed ID: 12161153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
    Meyer MD; Altenbach RJ; Bai H; Basha FZ; Carroll WA; Kerwin JF; Lebold SA; Lee E; Pratt JK; Sippy KB; Tietje K; Wendt MD; Brune ME; Buckner SA; Hancock AA; Drizin I
    J Med Chem; 2001 Jun; 44(12):1971-85. PubMed ID: 11384242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):271-6. PubMed ID: 17315538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
    Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
    J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.
    Qian W; Chen JJ; Human J; Aya T; Zhu J; Biswas K; Peterkin T; Hungate RW; Arik L; Johnson E; Kumar G; Joseph S; Jona J; Guo HX; Wu Z
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1061-7. PubMed ID: 22197141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative structure-activity relationships of alpha1 adrenergic antagonists.
    Eric S; Solmajer T; Zupan J; Novic M; Oblak M; Agbaba D
    J Mol Model; 2004 Apr; 10(2):139-50. PubMed ID: 14997365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists.
    Letourneau JJ; Riviello CM; Li H; Cole AG; Ho KK; Zanetakos HA; Desai H; Zhao J; Auld DS; Napier SE; Thomson FJ; Goan KA; Morphy JR; Ohlmeyer MH; Webb ML
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5394-7. PubMed ID: 20719508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.
    DiPardo RM; Patane MA; Newton RC; Price R; Broten TP; Chang RS; Ransom RW; Di Salvo J; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1959-62. PubMed ID: 11459670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes.
    Rossier O; Abuin L; Fanelli F; Leonardi A; Cotecchia S
    Mol Pharmacol; 1999 Nov; 56(5):858-66. PubMed ID: 10531388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computer modeling of size and shape descriptors of alpha 1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships.
    Montorsi M; Menziani MC; Cocchi M; Fanelli F; De Benedetti PG
    Methods; 1998 Mar; 14(3):239-54. PubMed ID: 9571081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.
    Wetzel JM; Miao SW; Forray C; Borden LA; Branchek TA; Gluchowski C
    J Med Chem; 1995 May; 38(10):1579-81. PubMed ID: 7752182
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of alpha 1-adrenoceptor antagonists in plasma by radioreceptor assay.
    Yamada S; Tanaka C; Suzuki M; Ohkura T; Kimura R; Kawabe K
    J Pharm Biomed Anal; 1996 Jan; 14(3):289-94. PubMed ID: 8851753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.